Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$14M
4 rounds on record
Latest round
$11.4M
Venture round · Sep 2026 · 1 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 17 Raised a round Venture round $11.4M · SEC Form D Nov 21, 2023 Raised a round Venture round $575k · SEC Form D Aug 9, 2022 Raised a round Venture round $2M · SEC Form D May 15, 2022 Raised a round Venture round $22 · SEC Form D 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2026 $11.4M — SEC Form D
Venture round Nov 2023 $575k — SEC Form D
Venture round Aug 2022 $2M — SEC Form D
Venture round May 2022 $22 — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Vetmab Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Denise BeversExecutive Officer, DirectorSEC Form D
Richard ChinExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
StarnatxSeries B $40M · 5 mo ago • Founded 2021 • 51-200 employees
星锐医药(Starna Therapeutics) 成立于2021年8月,公司聚焦肝外靶向递送技术,致力于研发以RNA为核心的创新药物,解决未被满足的临床需求。核心团队来自知名药企、高校和研究院所,团队拥有深厚的核酸药物发现、递送技术和制剂开发能力。.
Multiomic HealthVenture round · 3 mo ago • Founded 2021 • 11-50 employees
ABOUT.. MultiOmic Health has built a platform for discovering and developing life-changing precision medicines for age-related chronic…
Noctrix HealthVenture round $16.9M · 5 yr ago • Founded 2018 • 51-200 employees • 9 roles
Innovative technology for life-changing care At Noctrix Health, Inc. we are developing the next generation of clinically validated wearable…
Akston Biosciences >>11-50 employees
BIOTECH BUILT FOR PETS. We design, develop, and manufacture the protein therapeutics our pets deserve.
RQ Biotechnology11-50 employees
RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe…
Abbott develops life-changing medical devices for cardiovascular conditions.

Overview

Developing Life-Changing Therapeutics For Our Pets Monoclonal antibodies (mAbs) for modern veterinary practices Developing Life-Changing Therapeutics For Our Pets Monoclonal... Read More.

People

Denise Bevers
Executive Officer, Director
Richard Chin
Executive Officer, Director
Hangjun Zhan
Director
Neeraj Agrawal
Director
Chrysa Mineo
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego United States
HQ
10-50 est. staff

Financials

Total raised
$14M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $11.4M Details
Venture - Series Unknown 2023 $575k Details
Venture - Series Unknown 2022 $2M Details
Venture - Series Unknown 2022 $22 Details